# COVANCE INC

COVANCE INC is a company headquartered in Princeton, NJ, United States.

## Company overview

- **Legal name:** COVANCE INC
- **Former names in filing history:** CORNING PHARMACEUTICAL SERVICES INC (1996-11-19 to 1996-11-06)
- **Classification:** Company
- **Industry (SIC):** 8731 — Services-Commercial Physical & Biological Research
- **Headquarters:** Princeton, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001023131

## About

COVANCE INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001023131, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2014-02-27, it reported annual revenue of USD 2,595,130,000; net income of USD 179,207,000; total assets of USD 2,556,588,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $2.6B (USD 2,595,130,000)
- **Net income:** $179.2M (USD 179,207,000)
- **Total assets:** $2.6B (USD 2,556,588,000)
- **Cash and equivalents:** $617.7M (USD 617,686,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $2.4B (USD 2,365,759,000)
- **Net income:** $94.7M (USD 94,732,000)
- **Total assets:** $2.3B (USD 2,288,342,000)
- **Cash and equivalents:** $492.8M (USD 492,824,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $2.2B (USD 2,236,446,000)
- **Net income:** $132.2M (USD 132,189,000)
- **Total assets:** $2.1B (USD 2,108,008,000)
- **Cash and equivalents:** $389.1M (USD 389,103,000)

### FY2010 (period ended 2010-12-31)

- **Revenue:** $2.0B (USD 2,038,473,000)
- **Net income:** $68.3M (USD 68,254,000)
- **Total assets:** $2.0B (USD 1,965,542,000)
- **Cash and equivalents:** $377.2M (USD 377,223,000)
- **Operating cash flow:** $334.4M (USD 334,423,000)

## Recent SEC filings

- Form 8-K — filed 2015-02-19 — period 2015-02-19 — CURRENT REPORT
- Form 8-K — filed 2015-02-18 — period 2015-02-18 — CURRENT REPORT
- Form 8-K — filed 2015-02-09 — period 2015-02-09 — CURRENT REPORT
- Form 8-K — filed 2015-02-04 — period 2015-02-04 — 8-K
- Form 8-K — filed 2015-01-12 — period 2015-01-12 — CURRENT REPORT
- Form 10-Q — filed 2014-11-05 — period 2014-09-30 — 10-Q
- Form 8-K — filed 2014-11-04 — period 2014-11-02 — CURRENT REPORT
- Form 8-K — filed 2014-11-03 — period 2014-11-03 — 8-K
- Form 10-Q — filed 2014-08-01 — period 2014-06-30 — 10-Q
- Form 8-K — filed 2014-07-30 — period 2014-07-29 — 8-K
- Form 8-K — filed 2014-06-06 — period 2014-06-02 — 8-K
- Form 8-K — filed 2014-05-09 — period 2014-05-06 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/covance-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology